Professor of Oncology Johns Hopkins Baltimore, Maryland, United States
Describe the challenges associated with detecting FLT3-ITD mutations and the use of FLT3-ITD MRD in managing patients. Learning objectives: 1. Understand the differences between conventional capillary electrophoresis methods and amplicon-based methods for detection and quantification of FLT3-ITD mutations 2. Understand the prognostic implications for different levels of FLT3-ITD MRD
